4th Quarter - Report

STONE MATTHEIS XENOPOULOS AND BREW, PC for AMERICAN MEDICAL TECHNOLOGISTS

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing. Oppose reductions to Medicare Clinical Laboratory Fee Schedule.

LobbyistCovered position, as disclosed
PATRICK BURCHETTE —
MICHAEL N MCCARTY —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDA initiatives to regulate laboratory-developed diagnostic tests; legislation concerning regulation of laboratory-developed diagnostic tests (including H.R. 3207); support Taking Essential Steps for Testing Act (H.R. 6118; S.3391).

LobbyistCovered position, as disclosed
PATRICK BURCHETTE —
MICHAEL N MCCARTY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: S. 3391 (112th), H.R. 6118 (112th), H.R. 3207 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.